Comparing laparoscopic ultrasound and fluorescence imaging with indocyanine green to map bile ducts during difficult laparoscopic gallbladder removal
Official title: Laparoscopic Ultrasound Versus Fluorescence Cholangiography in Technically Challenging Laparoscopic Cholecystectomy. Multicenter Comparative Study
Run by Consorci Sanitari Integral · NCT07400237 · Data updated 2026-11-12
This will try two imaging methods—laparoscopic ultrasound and fluorescence cholangiography with indocyanine green—in adults having technically difficult laparoscopic gallbladder removal to see which shows the bile duct anatomy best.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 62 (estimated) |
| Sponsor | Consorci Sanitari Integral Academic / other |
| Locations | 1 site (Sant Joan Despí, Barcelona) |
| Status | Recruiting |
| Started | April 1, 2025 |
| Main results expected | December 2026 |
| Study ends | December 2027 |
| Registry record updated | February 10, 2026 |
| Trial ID | NCT07400237 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (age ≥18) scheduled for laparoscopic cholecystectomy who are expected to have technical difficulty (for example acute cholecystitis, prior upper abdominal surgery, previous biliary interventions, or BMI ≥30) and who can give informed consent are ideal candidates.
✕Probably not a fit
People with known allergy to ICG or iodine, pregnancy or breastfeeding, high risk of common bile duct stones, thyroid disease, suspected gallbladder cancer, ASA class IV–V, advanced chronic kidney disease, or those planned for open cholecystectomy are excluded and unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a multicenter, prospective interventional study in which each participant will receive both laparoscopic ultrasound (LUS) and fluorescence cholangiography with indocyanine green (ICG) during the same operation to allow direct within-patient comparison. LUS is performed first, followed by ICG fluorescence imaging prior to dissection of Calot's triangle using a standardized sequence. The primary endpoint is successful identification of the critical junction; secondary endpoints include visualization of individual biliary structures, time to visualization, total operative time, and intra- and postoperative complications. The trial focuses on cases anticipated to be technically difficult, such as acute cholecystitis, prior upper abdominal surgery, prior biliary disease, or obesity.
Why it matters
Potential benefit: If successful, better intraoperative imaging could lower the risk of bile duct injury and improve safety during difficult gallbladder operations.
How similar studies have gone: Both laparoscopic ultrasound and ICG fluorescence have been used successfully to visualize biliary anatomy in prior series, but direct head-to-head comparisons in technically challenging cases are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 18 years. 2. Written informed consent provided. 3. Indication for laparoscopic cholecystectomy with anticipated technical difficulty due to one or more of the following: * Acute cholecystitis. * Previous cholangitis, pancreatitis, or endoscopic retrograde cholangiopancreatography. * Prior upper abdominal surgery. * Obesity (Body Mass Index ≥ 30 kg/m²). Exclusion Criteria: 1. Known allergy to ICG or iodine. 2. Pregnancy or breastfeeding. 3. High risk of choledocholithiasis (ESGE guidelines). 4. Thyroid disease. 5. Suspected gallbladder malignancy. 6. ASA class IV-V. 7. Chronic kidney disease stage \> IIIb. 8. Planned open cholecystectomy.
Where it's running
-
Complex Hospitalari Universitari Moisès Broggi, Consorci Sanitari Integral
Sant Joan Despí, Barcelona, Spain Recruiting
Study contacts
- Study coordinator: Andrea Sanz LLorente, M.D.
- Email: andreasanz@uic.es
- Phone: +34 93 5531200
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PEG bowel preparation effects on gut microbes after gallbladder removal
This study tests whether PEG-based colonoscopy prep causes larger or longer-lasting changes to gut microbes in adults who have had their gallbladder removed compared with people who still have their gallbladder.
-
Real-time AI labeling of critical anatomy during laparoscopic gallbladder removal
This project will try a real-time AI algorithm to label key anatomical structures in laparoscopic cholecystectomy videos to help surgeons avoid bile duct injuries.
-
Robotic versus laparoscopic gallbladder removal for benign gallbladder disease
This trial will test whether robotic gallbladder removal is as safe as standard laparoscopic surgery for adults who need their gallbladder removed for benign disease.
-
How genetic differences affect nalbuphine pain relief after abdominal or pelvic surgery
We will test whether genetic differences change how well nalbuphine relieves pain after abdominal or pelvic surgery in adults.
-
Stanford program to advance robotic surgery for children and adolescents
This program will try the da Vinci Xi surgical robot in children and adolescents (ages 6–21, ≥15 kg) to see if it is safe and works well for procedures like sleeve gastrectomy, cholecystectomy, splenectomy, hysterectomy, and operations for endometriosis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.